tert-Butyl(2-chloroethyl)amine hydrochloride, 25g

Nazartinib, 250mg

3-Bromo-5-chloro-1-[(4-methylphenyl)sulfonyl]-1H-pyrrolo[2,3-b]pyridine, 95.0%, 1g

1-(2-METHYL-2H-INDAZOL-6-YL)ETHANONE, 95.0%, 1g

Indium-thd 99.9% 10 g

3-Chloro-5-(trifluoromethyl)pyridazine, 95.0%, 250mg

3,5-Dimethylisoxazole-4-carboxylic acid, 98.0%, 1g

8-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,4-dioxaspiro[4.5]decane, 95.0%, 5g

(2E)-3-(4-bromophenyl)-1-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 10g

4-tert-Butoxystyrene (stabilized with TBC)>98%(GC)100mL

4-Acetamidobenzenesulfonyl azide, 97.0%, 100g

Ethyl 2-ethoxy-1-[[(2'-cyanobiphenyl-4-yl)methyl]benzimidazole]-7-carboxylate, 95.0%, 1g

8-Chlorooctan-1-ol, 95.0%, 25g